Cardiovascular disease prevention guidelines set targets for controlling atherosclerotic cholesterol.
The Failure to achieve lipid goals It is concerning because it is directly related to a higher recurrence rate Atherosclerosis, cardiovascular disease It carries a high economic and social cost. Therefore, it is necessary to ensure that health care workers, on the one hand, and patients themselves, on the other hand, make appropriate use of available therapeutic resources.
This was shown in the V Cardiovascular Conference that the Spanish Society of General Practitioners and Family Physicians (SEMG) in Madrid on October 1 and 2 with The Seventh Diabetes Training Forum under the slogan “United in Cardiovascular Health”“The current control of cholesterol concentration, which is associated with low-density lipoproteins in patients with cardiovascular atherosclerosis, is very poor and this is associated with an increased risk of cardiovascular complications,” according to Miguel Angel Baena Lopez, a member of the SEMG Cardiovascular Working Group.
In addition, as he noted at the conference, the later these goals are achieved, the greater the stakes will be. “This is mainly due to Currently insufficient use of lipid-lowering therapies Available “.
The Cardiovascular disease prevention guidelines They set targets for atherosclerotic cholesterol control for patients with increased atherosclerotic-related cardiovascular disease (<55 mg/dL) and adapt to different risk factors, including different variables of atherosclerotic disease severity, presence of comorbidities, and risk factors. Others associated with cardiovascular disease.
Although it is well known that lowering LDL levels is associated with a significant reduction in the risk of CV events, “the truth is that although there are sufficient tools to achieve adequate control in most people with ischemic heart disease, the majority do not. Specific censorship,” according to Baena.
Although this situation is worrisome in the hyperlipidemic population in general, it is more severe in the patient in secondary prevention. For these reasons, from Spanish Society of Cardiology (SEC) proposed to create simple and easy-to-apply approach algorithms, which cover most clinical cases in the field of prevention
Moreover, in this consensus of the SEC with Recommendations for better fat control – In which the SEMG participated by Dr. Isabel Egochia, together with experts in the field of dyslipidemia from different specialties (cardiology, internal medicine and primary care) – Certain patient profiles were included in the cardiovascular risk table suggested by the European Dyslipidemia Guidelines , for primary and secondary prevention.
Although it may contain statements, statements or notes from health institutions or professionals, the information in medical writing is edited and prepared by journalists. We recommend that the reader be consulted on any health-related question with a healthcare professional.
“Creator. Devoted pop culture specialist. Certified web fanatic. Unapologetic coffee lover.”